Evidence map›Paper›PMID 38124059›Full record

ArticleBMC public health2023

Use of nicotine replacement therapy to reduce children's exposure to second-hand smoke in the home: a qualitative pilot study involving local community pharmacies.

Rebecca Howell, Stephen McBurney, Giovanna Di Tano, Aileen Boags, Neneh Rowa-Dewar, Ruaraidh Dobson, Rachel O'Donnell

Abstract read
In one paragraph

Article in BMC public health, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Rebecca HowellInstitute for Social Marketing and Health, Faculty of Health Sciences and Sport, University of Stirling, Stirling, FK9 4LA, Scotland, UK.
Stephen McBurneyNHS Lothian, Edinburgh, EH1 3EG, Scotland, UK.
Giovanna Di TanoNHS Lothian, Edinburgh, EH1 3EG, Scotland, UK.
Aileen BoagsNHS Lothian, Edinburgh, EH1 3EG, Scotland, UK.
Neneh Rowa-DewarUsher Institute, University of Edinburgh, Edinburgh, EH8 9AG, Scotland, UK.
Ruaraidh DobsonInstitute for Social Marketing and Health, Faculty of Health Sciences and Sport, University of Stirling, Stirling, FK9 4LA, Scotland, UK.
Rachel O'DonnellInstitute for Social Marketing and Health, Faculty of Health Sciences and Sport, University of Stirling, Stirling, FK9 4LA, Scotland, UK. r.c.odonnell@stir.ac.uk.ORCID 0000-0003-2713-1847

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundIn Scotland, and in several other countries, most second-hand smoke exposure now occurs in low-income households, where housing constraints and sole parenting often make it harder to create a smoke-free home. This pilot study provided people who smoke with a free 12-week supply of nicotine replacement therapy through local community pharmacies to reduce smoking indoors.

methodsTwenty-five parents/caregivers who smoked in the home and cared for children at least weekly were recruited via Facebook during the COVID-19 pandemic. Air quality (PM

resultsThree participants reported smoking outdoors only, one of whom subsequently quit smoking. Six participants reported reduced cigarette consumption by 50% in the home, four reported no (sustained) reduction and one reported increased smoking indoors. Self-reported outcomes were not always consistent with PM

conclusionAccess to free nicotine replacement therapy for temporary use indoors may support some people who smoke to reduce children's exposure to second-hand smoke. Our findings confirm the need to modify the intervention before undertaking a definitive trial to assess the effectiveness of this approach. This work is now underway.

Indexed as

PharmaciesSmoking CessationTobacco Smoke PollutionChildHumansNicotine Replacement TherapyPandemicsPilot ProjectsTobacco Use Cessation DevicesTobacco Smoke PollutionNicotine replacement therapiesPharmaciesPublic healthQualitativeSecond-hand smokeSmoke-free home

Identifiers

PMID38124059
PMCPMC10731720

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.